Being honest about this helps to clarify where Ireland’s real interests lie
The US benefits from an unjust arrangement where pharmaceutical companies avoid US taxes by transferring patents to Irish subsidiaries and licensing them back for high fees, resulting in significant profit shifting. While Trump exploits this issue, he is right about Big Pharma's tax avoidance and Ireland's gain from this arrangement. The author suggests Ireland focus on becoming a research hub instead.
